Leveraging Adeno-Associated Viruses (AAVs) in therapeutic approaches for monogenic neurological diseases

Supplied by PerkinElmer on Wednesday, 07 September, 2022

Within the field of neurological diseases, there is great interest in looking at rare diseases of monogenic origin with the hope of developing disease-modifying gene therapies, as opposed to treatments for symptom management. Therefore, using relatively tunable systems like recombinant AAVs, scientists are also exploring in vivo gene delivery in parallel to ex vivo.

Learn about key strategies and innovations in this space that are enabling advanced gene therapy.

DOWNLOAD
5 Pages PDF
Related White Papers

Genomic DNA: extraction from whole blood

To find out how a DNA purification system isolates and purifies genomic DNA (gDNA) from whole...

[eBook] Therapeutic proteins: bioprocessing methods for mAb generation

How to optimise your bioprocess for monoclonal...

Monitoring secrets from North America’s largest healthcare services company

Learn about the cutting edge solutions McKesson implemented to optimise processes and deliver...

Content from other channels on our network

Six on the shelf: from frozen treats to smoothies & meal kits

58% of food manufacturers report less productivity, research finds

Leadership change at CCEP Australia next year

CCEP's $39.7m can line upgrade in Perth increases capacity 40%

ACCC alleges anti-competitive conduct by Australian egg producer

Testing Profinet I/O devices without a dedicated PLC

CCEP's $39.7m can line upgrade in Perth increases capacity 40%

Cybersecurity and digitalisation for Zimbabwe platinum mine

ENEOS opens Direct MCH large‍-‍scale demonstration plant in Brisbane

ARENA funds manufacturing of solar construction robots

Conviction and $20K fine follows "serious and prolonged" offending by former podiatrist

Supagas acquires Heeson Medical

Why digital resilience is becoming critical in aged care

Rapid-response discharge model targets bed block

A Good Cleaning Schedule: Best Practices for Healthcare Facilities

  • All content Copyright © 2026 Westwick-Farrow Pty Ltd